showed that siRNA could downregulate EGFR and inhibit head and neck squamous cell carcinoma (HNSCC) and they also showed that this increased the sensitivity of HNSCC to cisplatin, 5‐FU, and docetaxel. This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.